Optimal management of oligometastatic nasopharyngeal carcinoma

xlomafota13 shared this article with you from Inoreader Optimal management of oligometastatic nasopharyngeal carcinoma Via http://link.springer.com/journal/405,European archives of oto-rhino-laryngology,The European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino Eur Arch Otorhinolaryngol. 2021 Jun 5. doi: 10.1007/s00405-021-06918-y. Online ahead of print. ABSTRACT PURPOSE: Oligometastatic nasopharyngeal carcinoma (NPC) is a distinctive subset of metastatic NPC. Imaging examinations and biomarkers can screen out NPC patients with limited number of sites showing metastasis. Past studies have demonstrated the survival advantages of oligometastatic NPC over multiple metastatic NPC. The treatment strategies of de-novo oligometastatic NPC differ owing to the heterogeneity of this disease. This study aims to systematically review the characteristics and treatments of oligometastatic NPC. METHODS: PubMed, EMBASE, the Web of Science, and the Cochrane Library were used to search for publications with an emphasis on oligometastatic NPC. RESULTS: We have presented the current advances on the management of oligometastatic NPC, including the definition, diagnosis, biomarkers, classification, pro gnosis, subtype, especially systematic therapy, locoregional radiotherapy to the primary tumor, and treatments of the metastatic lesions. CONCLUSIONS: More well-designed prospective clinical trials that are exclusive for oligometastatic NPC are warranted to determine the best treatment paradigm. PMID:34089384 | DOI:10.1007/s00405-021-06918-y View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.